APO Research

APO RESEARCH · REPORT

Critical Care

Selected research

Market Outlook & Growth Opportunities

Global Critical Care Market Outlook and Growth Opportunities 2026

Market perspective

The global Critical Care market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Critical Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Critical Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Critical Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Critical Care market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Critical Care market include Jiangsu Yuyue Medical Equipment and Supply Co., Ltd., Hedy Medical Device Co., Ltd., Beijing Aeonmed Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Edan Instruments, Inc., Micomme Medical Technology Development Co., Ltd., Guangdong Biolight Meditech Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd. and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Critical Care market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Critical Care and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Critical Care revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Critical Care market.

Critical Care Segment by Company

Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.

Hedy Medical Device Co., Ltd.

Beijing Aeonmed Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Edan Instruments, Inc.

Micomme Medical Technology Development Co., Ltd.

Guangdong Biolight Meditech Co., Ltd.

Shenzhen Comen Medical Instruments Co., Ltd.

GE Healthcare

Philips

Dragerwerk

Getinge

Baxter

Hamilton

Critical Care Segment by Type

Ventilator

Kidney Machine

Monitor

Others

Critical Care Segment by Application

Adults

Newborns

Critical Care Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Critical Care status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Critical Care key companies, revenue, market share, and recent developments.

3. To split the Critical Care breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Critical Care market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Critical Care significant trends, drivers, influence factors in global and regions.

6. To analyze Critical Care competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Critical Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Critical Care and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Critical Care.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Critical Care industry.

Chapter 3: Detailed analysis of Critical Care company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Critical Care in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Critical Care in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Critical Care Industry Trends Table 2. Critical Care Industry Drivers Table 3. Critical Care Industry Opportunities and Challenges Table 4. Critical Care Industry Restraints Table 5. Global Critical Care Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Critical Care Revenue Share by Company (2021-2026) Table 7. Global Critical Care Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Critical Care Key Company Manufacturing Base & Headquarters Table 9. Global Critical Care Company, Product Type & Application Table 10. Global Critical Care Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Critical Care by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ventilator Table 15. Significant Companies of Kidney Machine Table 16. Significant Companies of Monitor Table 17. Significant Companies of Others Table 18. Global Critical Care Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Critical Care Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Critical Care Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Critical Care Sales Value Share by Type (2021-2026) Table 22. Global Critical Care Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Adults Table 24. Significant Companies of Newborns Table 25. Global Critical Care Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Critical Care Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Critical Care Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Critical Care Sales Value Share by Application (2021-2026) Table 29. Global Critical Care Sales Value Share by Application (2027-2032) Table 30. Global Critical Care Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Critical Care Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Critical Care Sales Value Share by Region (2021-2026) Table 33. Global Critical Care Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Critical Care Sales Value Share by Region (2027-2032) Table 35. Global Critical Care Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Critical Care Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Critical Care Sales Value Market Share by Country (2021-2026) Table 38. Global Critical Care Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Critical Care Sales Value Market Share by Country (2027-2032) Table 40. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Company Information Table 41. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Business Overview Table 42. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Critical Care Product Portfolio Table 44. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Recent Development Table 45. Hedy Medical Device Co., Ltd. Company Information Table 46. Hedy Medical Device Co., Ltd. Business Overview Table 47. Hedy Medical Device Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Hedy Medical Device Co., Ltd. Critical Care Product Portfolio Table 49. Hedy Medical Device Co., Ltd. Recent Development Table 50. Beijing Aeonmed Co., Ltd. Company Information Table 51. Beijing Aeonmed Co., Ltd. Business Overview Table 52. Beijing Aeonmed Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Beijing Aeonmed Co., Ltd. Critical Care Product Portfolio Table 54. Beijing Aeonmed Co., Ltd. Recent Development Table 55. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information Table 56. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview Table 57. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Critical Care Product Portfolio Table 59. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Development Table 60. Edan Instruments, Inc. Company Information Table 61. Edan Instruments, Inc. Business Overview Table 62. Edan Instruments, Inc. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Edan Instruments, Inc. Critical Care Product Portfolio Table 64. Edan Instruments, Inc. Recent Development Table 65. Micomme Medical Technology Development Co., Ltd. Company Information Table 66. Micomme Medical Technology Development Co., Ltd. Business Overview Table 67. Micomme Medical Technology Development Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Micomme Medical Technology Development Co., Ltd. Critical Care Product Portfolio Table 69. Micomme Medical Technology Development Co., Ltd. Recent Development Table 70. Guangdong Biolight Meditech Co., Ltd. Company Information Table 71. Guangdong Biolight Meditech Co., Ltd. Business Overview Table 72. Guangdong Biolight Meditech Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Guangdong Biolight Meditech Co., Ltd. Critical Care Product Portfolio Table 74. Guangdong Biolight Meditech Co., Ltd. Recent Development Table 75. Shenzhen Comen Medical Instruments Co., Ltd. Company Information Table 76. Shenzhen Comen Medical Instruments Co., Ltd. Business Overview Table 77. Shenzhen Comen Medical Instruments Co., Ltd. Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shenzhen Comen Medical Instruments Co., Ltd. Critical Care Product Portfolio Table 79. Shenzhen Comen Medical Instruments Co., Ltd. Recent Development Table 80. GE Healthcare Company Information Table 81. GE Healthcare Business Overview Table 82. GE Healthcare Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GE Healthcare Critical Care Product Portfolio Table 84. GE Healthcare Recent Development Table 85. Philips Company Information Table 86. Philips Business Overview Table 87. Philips Critical Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Philips Critical Care Product Portfolio Table 89. Philips Recent Development Table 90. Dragerwerk Company Information Table 91. Dragerwerk Business Overview Table 92. Dragerwerk Critical Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Dragerwerk Critical Care Product Portfolio Table 94. Dragerwerk Recent Development Table 95. Getinge Company Information Table 96. Getinge Business Overview Table 97. Getinge Critical Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Getinge Critical Care Product Portfolio Table 99. Getinge Recent Development Table 100. Baxter Company Information Table 101. Baxter Business Overview Table 102. Baxter Critical Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Baxter Critical Care Product Portfolio Table 104. Baxter Recent Development Table 105. Hamilton Company Information Table 106. Hamilton Business Overview Table 107. Hamilton Critical Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Hamilton Critical Care Product Portfolio Table 109. Hamilton Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Critical Care Product Image Figure 2. Global Critical Care Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Critical Care Market Size (2021-2032) & (US$ Million) Figure 4. Global Critical Care Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ventilator Image Figure 8. Kidney Machine Image Figure 9. Monitor Image Figure 10. Others Image Figure 11. Global Critical Care Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Critical Care Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Critical Care Sales Value Share by Type (2021-2032) Figure 14. Adults Image Figure 15. Newborns Image Figure 16. Global Critical Care Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Critical Care Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Critical Care Sales Value Share by Application (2021-2032) Figure 19. Global Critical Care Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Critical Care Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Critical Care Sales Value (2021-2032) & (US$ Million) Figure 22. North America Critical Care Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Critical Care Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Critical Care Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Critical Care Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Critical Care Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Critical Care Sales Value (2021-2032) & (US$ Million) Figure 28. South America Critical Care Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Critical Care Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Critical Care Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Critical Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Critical Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Critical Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Ventilator
  • Kidney Machine
  • Monitor
  • Others
Applications
  • Adults
  • Newborns
Companies covered
  • Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
  • Hedy Medical Device Co., Ltd.
  • Beijing Aeonmed Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Edan Instruments, Inc.
  • Micomme Medical Technology Development Co., Ltd.
  • Guangdong Biolight Meditech Co., Ltd.
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • GE Healthcare
  • Philips
  • Dragerwerk
  • Getinge
  • Baxter
  • Hamilton

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Critical Care Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Critical Care Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Critical Care Market Dynamics
  1. 2.1 Critical Care Industry Trends
  2. 2.2 Critical Care Industry Drivers
  3. 2.3 Critical Care Industry Opportunities and Challenges
  4. 2.4 Critical Care Industry Restraints
3 Critical Care Market by Company
  1. 3.1 Global Critical Care Company Revenue Ranking in 2025
  2. 3.2 Global Critical Care Revenue by Company (2021-2026)
  3. 3.3 Global Critical Care Company Ranking (2024-2026)
  4. 3.4 Global Critical Care Company Manufacturing Base and Headquarters
  5. 3.5 Global Critical Care Company Product Type and Application
  6. 3.6 Global Critical Care Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Critical Care Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Critical Care Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Critical Care Market by Type
  1. 4.1 Critical Care Type Introduction
  2. 4.1.1 Ventilator
  3. 4.1.2 Kidney Machine
  4. 4.1.3 Monitor
  5. 4.1.4 Others
  6. 4.2 Global Critical Care Sales Value by Type
  7. 4.2.1 Global Critical Care Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Critical Care Sales Value by Type (2021-2032)
  9. 4.2.3 Global Critical Care Sales Value Share by Type (2021-2032)
5 Critical Care Market by Application
  1. 5.1 Critical Care Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Newborns
  4. 5.2 Global Critical Care Sales Value by Application
  5. 5.2.1 Global Critical Care Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Critical Care Sales Value by Application (2021-2032)
  7. 5.2.3 Global Critical Care Sales Value Share by Application (2021-2032)
6 Critical Care Regional Value Analysis
  1. 6.1 Global Critical Care Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Critical Care Sales Value by Region (2021-2032)
  3. 6.2.1 Global Critical Care Sales Value by Region: 2021-2026
  4. 6.2.2 Global Critical Care Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Critical Care Sales Value (2021-2032)
  7. 6.3.2 North America Critical Care Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Critical Care Sales Value (2021-2032)
  10. 6.4.2 Europe Critical Care Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Critical Care Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Critical Care Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Critical Care Sales Value (2021-2032)
  16. 6.6.2 South America Critical Care Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Critical Care Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Critical Care Sales Value Share by Country, 2025 VS 2032
7 Critical Care Country-level Value Analysis
  1. 7.1 Global Critical Care Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Critical Care Sales Value by Country (2021-2032)
  3. 7.2.1 Global Critical Care Sales Value by Country (2021-2026)
  4. 7.2.2 Global Critical Care Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Critical Care Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Critical Care Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Critical Care Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Critical Care Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Critical Care Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Critical Care Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Critical Care Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Critical Care Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Critical Care Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Critical Care Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Critical Care Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Critical Care Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Critical Care Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Critical Care Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Critical Care Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Critical Care Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Critical Care Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Critical Care Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Critical Care Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Critical Care Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Critical Care Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Critical Care Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Critical Care Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Critical Care Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Critical Care Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Critical Care Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Critical Care Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Critical Care Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Critical Care Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Critical Care Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Critical Care Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Critical Care Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Critical Care Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Critical Care Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Critical Care Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Critical Care Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Critical Care Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Critical Care Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Critical Care Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Critical Care Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Critical Care Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Critical Care Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Critical Care Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Critical Care Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Critical Care Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Critical Care Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Critical Care Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Critical Care Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Critical Care Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Critical Care Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Critical Care Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Critical Care Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Critical Care Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Critical Care Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Critical Care Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Critical Care Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Critical Care Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Critical Care Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Critical Care Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Critical Care Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Critical Care Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Critical Care Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Critical Care Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Critical Care Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Critical Care Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Critical Care Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Critical Care Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Critical Care Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Critical Care Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Critical Care Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Critical Care Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Critical Care Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Critical Care Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Critical Care Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Critical Care Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Critical Care Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Critical Care Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Critical Care Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Critical Care Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Critical Care Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Critical Care Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Critical Care Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Critical Care Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Critical Care Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
  2. 8.1.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Company Information
  3. 8.1.2 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Business Overview
  4. 8.1.3 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Critical Care Product Portfolio
  6. 8.1.5 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Recent Developments
  7. 8.2 Hedy Medical Device Co., Ltd.
  8. 8.2.1 Hedy Medical Device Co., Ltd. Company Information
  9. 8.2.2 Hedy Medical Device Co., Ltd. Business Overview
  10. 8.2.3 Hedy Medical Device Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hedy Medical Device Co., Ltd. Critical Care Product Portfolio
  12. 8.2.5 Hedy Medical Device Co., Ltd. Recent Developments
  13. 8.3 Beijing Aeonmed Co., Ltd.
  14. 8.3.1 Beijing Aeonmed Co., Ltd. Company Information
  15. 8.3.2 Beijing Aeonmed Co., Ltd. Business Overview
  16. 8.3.3 Beijing Aeonmed Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Aeonmed Co., Ltd. Critical Care Product Portfolio
  18. 8.3.5 Beijing Aeonmed Co., Ltd. Recent Developments
  19. 8.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  20. 8.4.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information
  21. 8.4.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview
  22. 8.4.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Critical Care Product Portfolio
  24. 8.4.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments
  25. 8.5 Edan Instruments, Inc.
  26. 8.5.1 Edan Instruments, Inc. Company Information
  27. 8.5.2 Edan Instruments, Inc. Business Overview
  28. 8.5.3 Edan Instruments, Inc. Critical Care Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Edan Instruments, Inc. Critical Care Product Portfolio
  30. 8.5.5 Edan Instruments, Inc. Recent Developments
  31. 8.6 Micomme Medical Technology Development Co., Ltd.
  32. 8.6.1 Micomme Medical Technology Development Co., Ltd. Company Information
  33. 8.6.2 Micomme Medical Technology Development Co., Ltd. Business Overview
  34. 8.6.3 Micomme Medical Technology Development Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Micomme Medical Technology Development Co., Ltd. Critical Care Product Portfolio
  36. 8.6.5 Micomme Medical Technology Development Co., Ltd. Recent Developments
  37. 8.7 Guangdong Biolight Meditech Co., Ltd.
  38. 8.7.1 Guangdong Biolight Meditech Co., Ltd. Company Information
  39. 8.7.2 Guangdong Biolight Meditech Co., Ltd. Business Overview
  40. 8.7.3 Guangdong Biolight Meditech Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Biolight Meditech Co., Ltd. Critical Care Product Portfolio
  42. 8.7.5 Guangdong Biolight Meditech Co., Ltd. Recent Developments
  43. 8.8 Shenzhen Comen Medical Instruments Co., Ltd.
  44. 8.8.1 Shenzhen Comen Medical Instruments Co., Ltd. Company Information
  45. 8.8.2 Shenzhen Comen Medical Instruments Co., Ltd. Business Overview
  46. 8.8.3 Shenzhen Comen Medical Instruments Co., Ltd. Critical Care Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shenzhen Comen Medical Instruments Co., Ltd. Critical Care Product Portfolio
  48. 8.8.5 Shenzhen Comen Medical Instruments Co., Ltd. Recent Developments
  49. 8.9 GE Healthcare
  50. 8.9.1 GE Healthcare Company Information
  51. 8.9.2 GE Healthcare Business Overview
  52. 8.9.3 GE Healthcare Critical Care Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GE Healthcare Critical Care Product Portfolio
  54. 8.9.5 GE Healthcare Recent Developments
  55. 8.10 Philips
  56. 8.10.1 Philips Company Information
  57. 8.10.2 Philips Business Overview
  58. 8.10.3 Philips Critical Care Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Philips Critical Care Product Portfolio
  60. 8.10.5 Philips Recent Developments
  61. 8.11 Dragerwerk
  62. 8.11.1 Dragerwerk Company Information
  63. 8.11.2 Dragerwerk Business Overview
  64. 8.11.3 Dragerwerk Critical Care Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dragerwerk Critical Care Product Portfolio
  66. 8.11.5 Dragerwerk Recent Developments
  67. 8.12 Getinge
  68. 8.12.1 Getinge Company Information
  69. 8.12.2 Getinge Business Overview
  70. 8.12.3 Getinge Critical Care Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Getinge Critical Care Product Portfolio
  72. 8.12.5 Getinge Recent Developments
  73. 8.13 Baxter
  74. 8.13.1 Baxter Company Information
  75. 8.13.2 Baxter Business Overview
  76. 8.13.3 Baxter Critical Care Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Baxter Critical Care Product Portfolio
  78. 8.13.5 Baxter Recent Developments
  79. 8.14 Hamilton
  80. 8.14.1 Hamilton Company Information
  81. 8.14.2 Hamilton Business Overview
  82. 8.14.3 Hamilton Critical Care Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hamilton Critical Care Product Portfolio
  84. 8.14.5 Hamilton Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research